5-bromo-6-chloro-N-[[(2R)-1-[2-[(3S)-3-[[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonylamino]-2-oxopiperidin-1-yl]acetyl]pyrrolidin-2-yl]methyl]pyridine-3-sulfonamide

C23H26BrCl2N5O6S3 — CID 59056904

IUPAC5-bromo-6-chloro-N-[[(2R)-1-[2-[(3S)-3-[[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonylamino]-2-oxopiperidin-1-yl]acetyl]pyrrolidin-2-yl]methyl]pyridine-3-sulfonamide
SMILESO=C1[C@@H](NS(=O)(=O)/C=C/c2ccc(Cl)s2)CCCN1CC(=O)N1CCC[C@@H]1CNS(=O)(=O)c1cnc(Cl)c(Br)c1
InChIInChI=1S/C23H26BrCl2N5O6S3/c24-18-11-17(13-27-22(18)26)40(36,37)28-12-15-3-1-9-31(15)21(32)14-30-8-2-4-19(23(30)33)29-39(34,35)10-7-16-5-6-20(25)38-16/h5-7,10-11,13,15,19,28-29H,1-4,8-9,12,14H2/b10-7+/t15-,19+/m1/s1
InChIKeyRLSWAIMSVBBSTE-GAVBFIELSA-N
MW715.50 g/mol
LogP3.06
Rot. Bonds10

About 5-bromo-6-chloro-N-[[(2R)-1-[2-[(3S)-3-[[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonylamino]-2-oxopiperidin-1-yl]acetyl]pyrrolidin-2-yl]methyl]pyridine-3-sulfonamide

5-bromo-6-chloro-N-[[(2R)-1-[2-[(3S)-3-[[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonylamino]-2-oxopiperidin-1-yl]acetyl]pyrrolidin-2-yl]methyl]pyridine-3-sulfonamide (PubChem CID 59056904) has the molecular formula C23H26BrCl2N5O6S3 and a molecular weight of 715.50 g/mol. Its IUPAC name is 5-bromo-6-chloro-N-[[(2R)-1-[2-[(3S)-3-[[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonylamino]-2-oxopiperidin-1-yl]acetyl]pyrrolidin-2-yl]methyl]pyridine-3-sulfonamide.

Molecular Properties

Compound Name5-bromo-6-chloro-N-[[(2R)-1-[2-[(3S)-3-[[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonylamino]-2-oxopiperidin-1-yl]acetyl]pyrrolidin-2-yl]methyl]pyridine-3-sulfonamide
PubChem CID59056904
Molecular FormulaC23H26BrCl2N5O6S3
Molecular Weight715.50 g/mol
Exact Mass712.96
IUPAC Name5-bromo-6-chloro-N-[[(2R)-1-[2-[(3S)-3-[[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonylamino]-2-oxopiperidin-1-yl]acetyl]pyrrolidin-2-yl]methyl]pyridine-3-sulfonamide
SMILESO=C1[C@@H](NS(=O)(=O)/C=C/c2ccc(Cl)s2)CCCN1CC(=O)N1CCC[C@@H]1CNS(=O)(=O)c1cnc(Cl)c(Br)c1
InChIInChI=1S/C23H26BrCl2N5O6S3/c24-18-11-17(13-27-22(18)26)40(36,37)28-12-15-3-1-9-31(15)21(32)14-30-8-2-4-19(23(30)33)29-39(34,35)10-7-16-5-6-20(25)38-16/h5-7,10-11,13,15,19,28-29H,1-4,8-9,12,14H2/b10-7+/t15-,19+/m1/s1
InChIKeyRLSWAIMSVBBSTE-GAVBFIELSA-N
XLogP3.06
TPSA145.85 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds10
Heavy Atoms40
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500715.50
LogP ≤ 53.06
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}

Analyze 5-bromo-6-chloro-N-[[(2R)-1-[2-[(3S)-3-[[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonylamino]-2-oxopiperidin-1-yl]acetyl]pyrrolidin-2-yl]methyl]pyridine-3-sulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-bromo-6-chloro-N-[[(2R)-1-[2-[(3S)-3-[[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonylamino]-2-oxopiperidin-1-yl]acetyl]pyrrolidin-2-yl]methyl]pyridine-3-sulfonamide?
The IUPAC name of 5-bromo-6-chloro-N-[[(2R)-1-[2-[(3S)-3-[[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonylamino]-2-oxopiperidin-1-yl]acetyl]pyrrolidin-2-yl]methyl]pyridine-3-sulfonamide (CID 59056904) is 5-bromo-6-chloro-N-[[(2R)-1-[2-[(3S)-3-[[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonylamino]-2-oxopiperidin-1-yl]acetyl]pyrrolidin-2-yl]methyl]pyridine-3-sulfonamide.
What is the SMILES notation for 5-bromo-6-chloro-N-[[(2R)-1-[2-[(3S)-3-[[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonylamino]-2-oxopiperidin-1-yl]acetyl]pyrrolidin-2-yl]methyl]pyridine-3-sulfonamide?
The canonical SMILES for 5-bromo-6-chloro-N-[[(2R)-1-[2-[(3S)-3-[[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonylamino]-2-oxopiperidin-1-yl]acetyl]pyrrolidin-2-yl]methyl]pyridine-3-sulfonamide is O=C1[C@@H](NS(=O)(=O)/C=C/c2ccc(Cl)s2)CCCN1CC(=O)N1CCC[C@@H]1CNS(=O)(=O)c1cnc(Cl)c(Br)c1.
What is the InChIKey of 5-bromo-6-chloro-N-[[(2R)-1-[2-[(3S)-3-[[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonylamino]-2-oxopiperidin-1-yl]acetyl]pyrrolidin-2-yl]methyl]pyridine-3-sulfonamide?
The InChIKey is RLSWAIMSVBBSTE-GAVBFIELSA-N. The full InChI is InChI=1S/C23H26BrCl2N5O6S3/c24-18-11-17(13-27-22(18)26)40(36,37)28-12-15-3-1-9-31(15)21(32)14-30-8-2-4-19(23(30)33)29-39(34,35)10-7-16-5-6-20(25)38-16/h5-7,10-11,13,15,19,28-29H,1-4,8-9,12,14H2/b10-7+/t15-,19+/m1/s1.
What are the key properties of 5-bromo-6-chloro-N-[[(2R)-1-[2-[(3S)-3-[[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonylamino]-2-oxopiperidin-1-yl]acetyl]pyrrolidin-2-yl]methyl]pyridine-3-sulfonamide?
5-bromo-6-chloro-N-[[(2R)-1-[2-[(3S)-3-[[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonylamino]-2-oxopiperidin-1-yl]acetyl]pyrrolidin-2-yl]methyl]pyridine-3-sulfonamide has a molecular weight of 715.50 g/mol, XLogP of 3.06, 10 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 5-bromo-6-chloro-N-[[(2R)-1-[2-[(3S)-3-[[(E)-2-(5-chlorothiophen-2-yl)ethenyl]sulfonylamino]-2-oxopiperidin-1-yl]acetyl]pyrrolidin-2-yl]methyl]pyridine-3-sulfonamide is sourced from PubChem (CID 59056904), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).